Author: Site Editor Publish Time: 09-17-2026 Origin: Site
Non-surgical hair loss management now offers more options. Minoxidil and finasteride remain established treatments, but concerns about hormonal side effects and long-term medication use continue to drive clinics and distributors to look for new alternative or complementary options.
Over the past two years, exosomes have gained noticeable attention in scalp care. However, topical exosomes face a practical issue: the scalp barrier limits their penetration. Microneedling with exosomes for hair loss offers a way to help overcome this limitation.
Exosomes are extracellular vesicles naturally released by cells. They contain bioactive molecules, including proteins and nucleic acids, and are involved in cell-to-cell signaling and various tissue processes.
Microneedling with exosomes is a minimally invasive scalp treatment. Fine needles create microchannels in the scalp, after which exosomes are applied to the treated area. The aim is to support local scalp and hair follicle conditions while improving the delivery and absorption of active ingredients, helping to improve hair density and overall hair quality over multiple treatment sessions.
Better topical delivery. Microneedling creates temporary microchannels that may help topical exosomes reach deeper layers of the scalp than simple surface application.
More even coverage. Microneedling can treat the broader hair loss area rather than relying on point-by-point injection, allowing the topical product to be distributed across the target area.
A non-surgical treatment option. The approach can be incorporated into broader hair loss care when appropriate, giving clinics another option for patients who prefer non-surgical treatment.
Microneedling has broader evidence supporting its use in hair loss treatment, particularly as an adjunctive therapy. For exosome-based treatment of androgenetic alopecia, early studies have reported improvements in hair density and hair shaft thickness. Overall, the available research shows positive signals and trends, while relevant data continue to accumulate.
For combination therapies, early studies have also reported improvements in hair density and hair shaft diameter, with generally good short-term tolerability. The preliminary results are encouraging. As more medical institutions adopt this approach and more studies are conducted, its specific efficacy will become clearer.
Microneedling with exosomes combines controlled scalp microneedling with exosome application in the same treatment session. Each step should be properly performed to ensure a smooth and controlled treatment process.
First, a scalp assessment should be performed. For suitable patients, photos should be taken to record the initial condition of the scalp and hair.
A topical anesthetic cream may be used before treatment when necessary to improve patient comfort.
Microneedling is the core technical step of this treatment, with a commonly used depth of 1.5–2.0 mm. Whether using an electric microneedling pen or a roller, the hair loss area should be treated with even coverage.
Immediately after microneedling, exosomes should be applied to the treated area. The amount can be determined according to the product instructions and the size of the hair loss area. Excessive rubbing should be avoided after application.
Follow-up is necessary, but the schedule can be based on the clinic's own protocols and adjusted according to the patient's response, with maintenance treatments every 2–3 months. Photos should be taken during follow-up visits to more objectively track changes in hair density and overall condition, helping to guide and adjust subsequent treatment plans.
We use EXOBLOOM® Exosome Scalp Care, an exosome product specially designed for scalp and hair care. It uses a human umbilical cord blood-derived extract and contains a formula with 4 types of peptides and 14 growth factors, providing regenerative support for hair restoration and scalp care. It can also be used in professional treatment protocols such as microneedling.
In one case, a male patient received 2 mL of exosome treatment to improve scalp thinning. After three months, his hair appeared noticeably denser, with visible improvement in hair pigmentation and scalp coverage.
Below are before-and-after photos of other clients who received EXOBLOOM® Exosome Scalp Care treatment, showing visible improvements in hair density, texture, and natural shine within 3 months.
The most common discomfort comes from microneedling itself, including needle-prick sensations, burning, and tightness after treatment. These usually subside within 24–48 hours.
Risks can also arise from improper treatment or aftercare. Some patients may have an allergic reaction to the device materials or excipients in the exosome product. Persistent or worsening redness, pain, discharge, or other unusual reactions should be assessed by a doctor.
Microneedling with exosomes for hair loss combines controlled microchannel creation with exosome application in the same treatment. Current findings are encouraging, and as related applications and research continue to develop, this combination therapy is worth the attention of professional medical institutions.
For clinics interested in adding this approach to their existing hair care protocols, contact us for product specifications and cooperation information.
